The kinome 'at large' in cancer

被引:219
作者
Fleuren, Emmy D. G. [1 ]
Zhang, Luxi [2 ,3 ,4 ]
Wu, Jianmin [5 ]
Daly, Roger J. [2 ,3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[2] Monash Univ, Biomed Discovery Inst, Canc Program, Clayton, Vic 3800, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[4] Univ New S Wales, Sydney, NSW 2052, Australia
[5] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Div, 370 Victoria St, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
ACUTE MYELOID-LEUKEMIA; COMPREHENSIVE MOLECULAR CHARACTERIZATION; DNA-DAMAGE RESPONSE; CELL LUNG-CANCER; INTEGRATED GENOMIC CHARACTERIZATION; SYNTHETIC LETHAL INTERACTIONS; NEGATIVE BREAST-CANCER; PANCREATIC-CANCER; KINASE REQUIREMENTS; THERAPEUTIC TARGET;
D O I
10.1038/nrc.2015.18
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Over the past decade, rapid advances in genomics, proteomics and functional genomics technologies that enable in-depth interrogation of cancer genomes and proteomes and high-throughput analysis of gene function have enabled characterization of the kinome 'at large' in human cancers, providing crucial insights into how members of the protein kinase superfamily are dysregulated in malignancy, the context-dependent functional role of specific kinases in cancer and how kinome remodelling modulates sensitivity to anticancer drugs. The power of these complementary approaches, and the insights gained from them, form the basis of this Analysis article.
引用
收藏
页码:83 / 98
页数:16
相关论文
共 128 条
[1]
Integrated Genomic Characterization of Papillary Thyroid Carcinoma [J].
Agrawal, Nishant ;
Akbani, Rehan ;
Aksoy, B. Arman ;
Ally, Adrian ;
Arachchi, Harindra ;
Asa, Sylvia L. ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Baylin, Stephen B. ;
Behera, Madhusmita ;
Bernard, Brady ;
Beroukhim, Rameen ;
Bishop, Justin A. ;
Black, Aaron D. ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
Bowen, Jay ;
Bowlby, Reanne ;
Bristow, Christopher A. ;
Brookens, Robin ;
Brooks, Denise ;
Bryant, Robert ;
Buda, Elizabeth ;
Butterfield, Yaron S. N. ;
Carling, Tobias ;
Carlsen, Rebecca ;
Carter, Scott L. ;
Carty, Sally E. ;
Chan, Timothy A. ;
Chen, Amy Y. ;
Cherniack, Andrew D. ;
Cheung, Dorothy ;
Chin, Lynda ;
Cho, Juok ;
Chu, Andy ;
Chuah, Eric ;
Cibulskis, Kristian ;
Ciriello, Giovanni ;
Clarke, Amanda ;
Clayman, Gary L. ;
Cope, Leslie ;
Copland, John A. ;
Covington, Kyle ;
Danilova, Ludmila ;
Davidsen, Tanja ;
Demchok, John A. ;
DiCara, Daniel ;
Dhalla, Noreen .
CELL, 2014, 159 (03) :676-690
[2]
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations [J].
Ahronian, Leanne G. ;
Sennott, Erin M. ;
Van Allen, Eliezer M. ;
Wagle, Nikhil ;
Kwak, Eunice L. ;
Faris, Jason E. ;
Godfrey, Jason T. ;
Nishimura, Koki ;
Lynch, Kerry D. ;
Mermel, Craig H. ;
Lockerman, Elizabeth L. ;
Kalsy, Anuj ;
Gurski, Joseph M., Jr. ;
Bahl, Samira ;
Anderka, Kristin ;
Green, Lisa M. ;
Lennon, Niall J. ;
Huynh, Tiffany G. ;
Mino-Kenudson, Mari ;
Getz, Gad ;
Dias-Santagata, Dora ;
Iafrate, A. John ;
Engelman, Jeffrey A. ;
Garraway, Levi A. ;
Corcoran, Ryan B. .
CANCER DISCOVERY, 2015, 5 (04) :358-367
[3]
A pan-cancer proteomic perspective on The Cancer Genome Atlas [J].
Akbani, Rehan ;
Ng, Patrick Kwok Shing ;
Werner, Henrica M. J. ;
Shahmoradgoli, Maria ;
Zhang, Fan ;
Ju, Zhenlin ;
Liu, Wenbin ;
Yang, Ji-Yeon ;
Yoshihara, Kosuke ;
Li, Jun ;
Ling, Shiyun ;
Seviour, Elena G. ;
Ram, Prahlad T. ;
Minna, John D. ;
Diao, Lixia ;
Tong, Pan ;
Heymach, John V. ;
Hill, Steven M. ;
Dondelinger, Frank ;
Stadler, Nicolas ;
Byers, Lauren A. ;
Meric-Bernstam, Funda ;
Weinstein, John N. ;
Broom, Bradley M. ;
Verhaak, Roeland G. W. ;
Liang, Han ;
Mukherjee, Sach ;
Lu, Yiling ;
Mills, Gordon B. .
NATURE COMMUNICATIONS, 2014, 5
[4]
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer [J].
Al-Ejeh, Fares ;
Miranda, Mariska ;
Shi, Wei ;
Simpson, Peter T. ;
Song, Sarah ;
Vargas, Ana Cristina ;
Saunus, Jodi M. ;
Smart, Chanel E. ;
Mariasegaram, Mythily ;
Wiegmans, Adrian P. ;
Chenevix-Trench, Georgia ;
Lakhani, Sunil R. ;
Khanna, Kum Kum .
ONCOTARGET, 2014, 5 (10) :3145-3158
[5]
Cancer-Associated Protein Kinase C Mutations Reveal Kinase's Role as Tumor Suppressor [J].
Antal, Corina E. ;
Hudson, Andrew M. ;
Kang, Emily ;
Zanca, Ciro ;
Wirth, Christopher ;
Stephenson, Natalie L. ;
Trotter, Eleanor W. ;
Gallegos, Lisa L. ;
Miller, Crispin J. ;
Fumari, Frank B. ;
Hunter, Tony ;
Brognard, John ;
Newton, Alexandra C. .
CELL, 2015, 160 (03) :489-502
[6]
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer [J].
Azorsa, David O. ;
Gonzales, Irma M. ;
Basu, Gargi D. ;
Choudhary, Ashish ;
Arora, Shilpi ;
Bisanz, Kristen M. ;
Kiefer, Jeffrey A. ;
Henderson, Meredith C. ;
Trent, Jeffrey M. ;
Von Hoff, Daniel D. ;
Mousses, Spyro .
JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
[7]
Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors [J].
Bai, Yun ;
Li, Jiannong ;
Fang, Bin ;
Edwards, Arthur ;
Zhang, Guolin ;
Bui, Marilyn ;
Eschrich, Steven ;
Altiok, Soner ;
Koomen, John ;
Haura, Eric B. .
CANCER RESEARCH, 2012, 72 (10) :2501-2511
[8]
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity [J].
Bajrami, Ilirjana ;
Frankum, Jessica R. ;
Konde, Asha ;
Miller, Rowan E. ;
Rehman, Farah L. ;
Brough, Rachel ;
Campbell, James ;
Sims, David ;
Rafiq, Rumana ;
Hooper, Sean ;
Chen, Lina ;
Kozarewa, Iwanka ;
Assiotis, Ioannis ;
Fenwick, Kerry ;
Natrajan, Rachael ;
Lord, Christopher J. ;
Ashworth, Alan .
CANCER RESEARCH, 2014, 74 (01) :287-297
[9]
Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3 [J].
Baldwin, Amy ;
Grueneberg, Dorre A. ;
Hellner, Karin ;
Sawyer, Jacqueline ;
Grace, Miranda ;
Li, Wenliang ;
Harlow, Ed ;
Munger, Karl .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12463-12468
[10]
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia [J].
Banerji, Versha ;
Frumm, Stacey M. ;
Ross, Kenneth N. ;
Li, Loretta S. ;
Schinzel, Anna C. ;
Hahn, Cynthia K. ;
Kakoza, Rose M. ;
Chow, Kwan T. ;
Ross, Linda ;
Alexe, Gabriela ;
Tolliday, Nicola ;
Inguilizian, Haig ;
Galinsky, Ilene ;
Stone, Richard M. ;
DeAngelo, Daniel J. ;
Roti, Giovanni ;
Aster, Jon C. ;
Hahn, William C. ;
Kung, Andrew L. ;
Stegmaier, Kimberly .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (03) :935-947